Results 181 to 190 of about 58,087 (312)

The impact of re‐characterizing metastatic pancreatic neuroendocrine tumors: A prospective study

Journal of Neuroendocrinology, EarlyView.
Abstract The biology of metastatic pancreatic neuroendocrine tumors (panNET) may alter over time. It remains to be defined if, how, and when this patient group should be recommended to re‐evaluate the characteristics of their disease. This prospective single‐center, longitudinal cohort study at Uppsala University Hospital, Sweden (NCT03130205 ...
Kazhan Mollazadegan, Johan Botling, Britt Skogseid, Barbro Eriksson, Lovisa Falkman, Liang Zhang, Ieva Lase, Staffan Welin, Anders Sundin, Joakim Crona   +9 more
wiley   +1 more source

Navigating care: understanding cancer patients' experiences with systemic radionuclide therapy. [PDF]

Support Care Cancer
Starkbaum J, Thircuir S, Winkler F, Griessler E.   +3 more
europepmc   +2 more sources

Radionuclide therapy with 111In-pentetreoide in five digestive metastatic neuroendocrine tumors (DNET)

, 2000
Thomas Aparicio, Iradj Sobhani, Christian Nguyen, Rachida Lebrahi, Laurent Abramowitz, Dominique Le Guludec, S. Askienazy, M Mignon   +7 more
openalex   +1 more source

Whole-Body Dosimetry for Individualized Treatment Planning of ¹³¹I-MIBG Radionuclide Therapy for Neuroblastoma [PDF]

, 2009
Susan Buckley, Sarah Chittenden, Frank Saran, Simon Meller, Glenn Flux   +4 more
openalex   +1 more source

Evaluation of a novel radiofolate in tumour-bearing mice: promising prospects for folate-based radionuclide therapy [PDF]

, 2009
Cristina Müller, Thomas L. Mindt, Marion de Jong, Roger Schibli   +3 more
openalex   +1 more source

RADIATION-HYGIENIC JUSTIFICATION OF OUTPATIENT RADIONUCLIDE THERAPY

Радиационная гигиена, 2015
The possibility of the use of the different therapeutic radiopharmaceuticals labeled with one of the 19 β-γ-emitting radionuclides or 6 α-β-γ-emitting radionuclides in the outpatient regime was identified in the estimateinvestigations.
B. Ja. Narkevich, S. V. Shiryaev, A. N. Klyopov, N. N. Lipanova, Yu. V. Lysak   +4 more
doaj  

Beyond fluorodeoxyglucose: Molecular imaging of cancer in precision medicine

CA: A Cancer Journal for Clinicians, EarlyView.
Abstract Cancer molecular imaging is the noninvasive visualization of a process unique to or altered in neoplasia, such as proliferation, glucose metabolism, and receptor expression, which is relevant to patient management. Several molecular imaging modalities are now available, including magnetic resonance, optical, and nuclear imaging.
Malik E. Juweid, Soud F. Al‐Qasem, Fadlo R. Khuri, Andrea Gallamini, Philipp Lohmann, Hans‐Joachim Ziellenbach, Felix M. Mottaghy   +6 more
wiley   +1 more source

Comparative somatostatin receptor scintigraphy using In-111-DOTA-lanreotide and In-111-DOTA-Tyr3-octreotide versus F-18-FDG-PET for evaluation of somatostatin receptor-mediated radionuclide therapy

, 2001
Irene Virgolini, Pallavi Patri, C. Novotny, Tatjana Traub‐Weidinger, M. Leimer, Barbara Füger, Shuren Li, P. Angelberger, Markus Raderer, S. Wogritsch, Amir Kurtaran, Kurt Kletter, Robert Dudczak   +12 more
openalex   +1 more source

Targeted Radionuclide Therapy Using a Wnt-Targeted Replicating Adenovirus Encoding the Na/I Symporter [PDF]

, 2009
Inge Peerlinck, Andrew Merron, Patrick Baril, Sophie Conchon, Pilar Martín‐Duque, Cécilia Hindorf, Jerome Burnet, Miguel Quintanilla, Mohan Hingorani, Richard Iggo, Nicholas R. Lemoine, Kevin J. Harrington, Georges Vassaux   +12 more
openalex   +1 more source

Guideline for the Management Pathway and Quality Control of Breast Cancer Prevention and Treatment in China's Counties

Cancer Innovation, Volume 4, Issue 3, June 2025.
County hospitals bear the primary responsibility for health education, screening, primary diagnosis and treatment, maintenance treatment, management of adverse reactions to antitumor drugs, patient follow‐up, recurrence monitoring, rehabilitation guidance, and two‐way referrals for breast cancer.
Breast Cancer Expert Committee of National Cancer Quality Control Center, Cancer Prevention and Treatment Committee of Healthy China Research Center   +1 more
wiley   +1 more source